VERTEX PHARMACEUTICALS earnings per share and revenue

4VRTX earnings per share for the last quarter are 3.93 EUR whereas the estimation was 3.66 EUR which accounts for 7.41% surprise. Company revenue for the same period amounts to 2.49 B EUR despite the estimated figure of 2.41 B EUR. Estimated earnings per share for the next quarter are 3.71 EUR, and revenue is expected to reach 2.54 B EUR. Also watch annual changes over time to get a bigger picture of 4VRTX earnings per share and revenue dynamics.